Viatris: Undervalued But Selling Off Key Segments

October 16, 2023 Ogreman Stock Profile 0

Intro: Global Pharma

Ticker: VTRS

Recent Price and P/E Ratio: $9.33 and 6.12

52 Week Range: $12.4 to $8.84

Leader in its Industry or Niche? No

Dividend: 5.14%

Type of Investment: Speculation only even though it is very undervalued.

Be the first to comment

Leave a Reply

Your email address will not be published.


*